Article

Effect of Riboflavin Deficiency on the Metabolism of Oxypurines in Chicks

Authors:
To read the full-text of this research, you can request a copy directly from the author.

Abstract

Day-old broiler chicks of both sexes were used in three experiments to determine the effect of riboflavin deficiency on oxypurine metabolism catalyzed by xanthine dehydrogenase, a riboflavin-containing enzyme. Chicks fed a riboflavin-deficient diet (1.38 mg/kg) for 3 weeks exhibited depressed growth and a high incidence of curled-toe paralysis (higher than 80%) as compared to control chicks (15.1 mg riboflavin per kilogram diet; no incidence of curled-toe paralysis). In addition, the precursors of uric acid, hypoxanthine and/or xanthine, accumulated in the liver and kidney of deficient chicks showing curled-toe paralysis. These observations show that dietary riboflavin being incorporated into xanthine dehydrogenase is essential for oxypurine metabolism. Moreover in the chick, the liver and the kidney may be important sites of uric acid synthesis. The low uric acid concentration in the plasma of the deficient chicks appeared to be indicative of a disturbance in uric acid synthesis in the liver and kidney.

No full-text available

Request Full-text Paper PDF

To read the full-text of this research,
you can request a copy directly from the author.

Chapter
Riboflavin deficiency has been studied in many animal species and always results in failure to grow. This fact might be anticipated in view of the importance of flavoprotein enzymes in cellular metabolism. There have been reported a great variety of lesions, including changes in the skin, loss of hair, degenerative changes in the nervous system and liver, impaired reproduction, and congenital malformations in the offspring. Lesions of the cornea of the eye, cataract formation, and reduced formation of hemoglobin have also been reported. The specificity of some of these lesions has been questioned.
Article
Isolated chick liver and kidney cells produce urate de novo from glycine, and this is partially inhibited by 1 mm-AMP and by 1 mm-GMP in liver cells but not in kidney cells. Azaserine fully inhibits this synthesis de novo, but attempts to isolate formylglycine amide ribonucleotide from azaserine-blocked cells were unsuccessful.
ResearchGate has not been able to resolve any references for this publication.